Winslow Evans & Crocker’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,430
Closed -$40.1K 1314
2016
Q4
$40.1K Sell
1,430
-2,470
-63% -$69.2K 0.01% 581
2016
Q3
$107K Hold
3,900
0.03% 395
2016
Q2
$85.1K Hold
3,900
0.03% 416
2016
Q1
$87.1K Hold
3,900
0.03% 398
2015
Q4
$108K Buy
+3,900
New +$108K 0.03% 384

Other funds holding QGENF

Winslow Evans & Crocker's QGENF Position: Q1 2017 in Review

Winslow Evans & Crocker sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,430 shares — an estimated $40.1K sold.

Winslow Evans & Crocker first reported a position in QGENF in Q4 2015 and held it in 5 quarters. The position peaked at $108K in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Winslow Evans & Crocker reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Winslow Evans & Crocker sold 1,430 QIAGEN NV shares in Q1 2017, an estimated $40.1K.
  • Winslow Evans & Crocker first reported a position in QIAGEN NV in Q4 2015 and held it in 5 quarters.
  • Winslow Evans & Crocker's QIAGEN NV position peaked at $108K in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Winslow Evans & Crocker's 13F filing for Q1 2017, filed 14 Apr 2017.